Effects of exposure to negative and positive social media content about vaping and nicotine addiction on beliefs and intentions to use e-cigarettes among young adults in the United States: results from a randomized controlled experiment.

What Was Tested

Researchers studied Therapeutic nicotine (patch, non-peptide) in this randomized controlled trial publication.

Noncommercial social media content presents vaping and nicotine addiction in both positive and negative terms.

The effect of exposure to this content on young adults' attitudes, beliefs, and intentions to vape is unknown.

Who Took Part

According to the abstract, 1816 adults were involved.

The age groups tagged for this paper are teenagers, young adults and adults, both men and women.

The researchers randomized 1816 US young adults to view a series of real (ie, not simulated), noncommercial, publicly accessible social media videos about nicotine addiction of the same valence (positive, negative, or control unrelated to nicotine addiction).

How the Study Was Run

The design is described as randomized.

The adults were allocated by chance, so the Therapeutic nicotine (patch, non-peptide) group and the comparison group should start out alike.

Exposures included both YouTube and TikTok videos that had been uploaded to the YouTube platform.

The researchers explored associations between the social media exposure and intentions to use or quit e-cigarettes or cigarettes and related normative beliefs.

What Was Measured

Topics PubMed links to this paper include Social Media, Vaping, Electronic Nicotine Delivery Systems, United States, Tobacco Use Disorder, Media Exposure and Intention.

Author keywords: e-cigarettes, electronic cigarettes and young adults.

What This Means in Plain Language

The paper is a randomized study of Therapeutic nicotine (patch, non-peptide) in 1816 adults.

With several hundred people or more, it is a fairly large study for this kind of research.

Its findings take up roughly 8 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2026 (Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco), a journal based in England.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.